Highland Capital Management (Texas)’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-25,300
Closed -$679K 281
2019
Q1
$679K Buy
+25,300
New +$679K 0.04% 198
2017
Q2
Sell
-26,200
Closed -$901K 289
2017
Q1
$901K Buy
26,200
+6,200
+31% +$213K 0.05% 179
2016
Q4
$577K Buy
+20,000
New +$577K 0.03% 209
2014
Q2
Sell
-67,833
Closed -$1.65M 257
2014
Q1
$1.65M Buy
67,833
+22,833
+51% +$555K 0.07% 134
2013
Q4
$1.13M Buy
+45,000
New +$1.13M 0.06% 107